Zobrazeno 1 - 10
of 15
pro vyhledávání: '"S. A. Kozek-Langenecker"'
Publikováno v:
Anaesthesia. 60:554-559
The aim of this study was to investigate the effects of various gelatin and hydroxyethyl starch solutions on platelet reactivity. Citrated whole blood was obtained from 20 healthy volunteers. Expression of glycoprotein (GP) IIb-IIIa and p-selectin we
Autor:
S. A. Kozek-Langenecker
Publikováno v:
Der Anaesthesist. 52:549-566
New antiplatelet drugs such as glycoprotein IIb/IIIa receptor antagonists, thienopyridines (adenosine diphosphate receptor antagonists), inhibitors of cyclooxygenase and phosphodiesterase, and antiaggregatory prostaglandins have been introduced in va
Autor:
S. A. Kozek-Langenecker
Publikováno v:
Der Anaesthesist. 51:210-217
In der vorliegenden Ubersicht sollen die Mechanismen der Gerinnungsaktivierung wahrend kontinuierlicher Nierenersatztherapie in Form der Hamofiltration dargestellt werden. Die Aktivierung der Thrombozyten wurde als pathophysiologisch relevante Folge
Publikováno v:
European Journal of Anaesthesiology. 18:467-470
Autor:
S A, Kozek-Langenecker
Publikováno v:
Der Anaesthesist. 57(6)
The options for drug-controlled anticoagulation are becoming noticeably more manifold. In the area of anaesthesiology and intensive care, there are furthermore special disease patterns, such as heparin-induced thrombocytopenia (HIT) to be known, diag
Autor:
G, Pfanner, J, Koscielny, T, Pernerstorfer, M, Gütl, P, Perger, D, Fries, N, Hofmann, P, Innerhofer, W, Kneifl, L, Neuner, H, Schöchl, S A, Kozek-Langenecker
Publikováno v:
Der Anaesthesist. 56(6)
Unexpected bleeding in the perioperative period is largely caused by impaired inherited or drug-induced primary haemostasis. Standard tests for plasma coagulation are predominantly employed to gauge the risk of bleeding. In accordance with several re
Autor:
S A, Kozek-Langenecker, D, Fries, M, Gütl, N, Hofmann, P, Innerhofer, W, Kneifl, L, Neuner, P, Perger, T, Pernerstorfer, G, Pfanner, H, Schöchl
Publikováno v:
Der Anaesthesist. 54(5)
More efficacious anticoagulant and antiplatelet agents have been introduced in vascular medicine and in the prevention of perioperative venous thromboembolisms. Patient management should be guided by familiarity with the pharmacology of coagulation-a
Publikováno v:
Acta anaesthesiologica Scandinavica. 47(1)
Hydroxyethyl starches (HES) have been shown to decrease clot strength and to increase coagulation times assessed by thromboelastography (TEG). HES with minimal anticoagulant side-effects is beneficial for plasma volume expansion in the perioperative
Autor:
S A, Kozek-Langenecker
Publikováno v:
Wiener klinische Wochenschrift. 111(4)
This paper reviews pathophysiological processes occurring after contact of blood with artificial surfaces and the predominant role of platelets in the genesis of extracorporeal thrombosis. Bleeding complications are common during conventional heparin
Publikováno v:
Infusionstherapie und Transfusionsmedizin. 22(5)
Changes in hemostasis during orthotopic liver transplantation (OLT) and an intraoperative bleeding complication requiring massive transfusion are discussed.The monitoring of hemostasis included bed-sided thromboelastography, measurement of in vitro p